16. Assessing the role of ABL2 in the progression of alcohol-associated liver disease von Keating, C.R., Malnassy, G., Gad, S., Ding, X., Sun, Z., Koleske, A., Qiu, W.

Volltext

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia von Madan, V, Shyamsunder, P, Han, L, Mayakonda, A, Nagata, Y, Sundaresan, J, Kanojia, D, Yoshida, K, Ganesan, S, Hattori, N, Fulton, N, Tan, K-T, Alpermann, T, Kuo, M-C, Rostami, S, Matthews, J, Sanada, M, Liu, L-Z, Shiraishi, Y, Miyano, S, Chendamarai, E, Hou, H-A, Malnassy, G, Ma, T, Garg, M, Ding, L-W, Sun, Q-Y, Chien, W, Ikezoe, T, Lill, M, Biondi, A, Larson, R A, Powell, B L, Lübbert, M, Chng, W J, Tien, H-F, Heuser, M, Ganser, A, Koren-Michowitz, M, Kornblau, S M, Kantarjian, H M, Nowak, D, Hofmann, W-K, Yang, H, Stock, W, Ghavamzadeh, A, Alimoghaddam, K, Haferlach, T, Ogawa, S, Shih, L-Y, Mathews, V, Koeffler, H P

Volltext

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909 von LIU, Hongtao, JOHNSON, Jeffrey L, STOCK, Wendy, KOVAL, Greg, MALNASSY, Greg, SHER, Dorie, DAMON, Lloyd E, HSI, Eric D, BUCCI, Donna Marie, LINKER, Charles A, CHESON, Bruce D

Volltext

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia von Madan, V, Shyamsunder, P, Han, L, Mayakonda, A, Nagata, Y, Sundaresan, J, Kanojia, D, Yoshida, K, Ganesan, S, Hattori, N, Fulton, N, Tan, K T, Alpermann, T, Kuo, M C, Rostami, S, Matthews, J, Sanada, M, Liu, L-Z, Shiraishi, Y, Miyano, S, Chendamarai, E, Hou, H A, Malnassy, G, Ma, T, Garg, M, Ding, L W, Sun, Q Y, Chien, W, Ikezoe, T, Lill, M, Biondi, A, Larson, R A, Powell, B L, Lübbert, M, Chng, W J, Tien, H F, Heuser, M, Ganser, A, Koren-Michowitz, M, Kornblau, S M, Kantarjian, H M, Nowak, D, Hofmann, W K, Yang, H, Stock, W, Ghavamzadeh, A, Alimoghaddam, K, Haferlach, T, Ogawa, S, Shih, L Y, Mathews, V, Koeffler, H P

Volltext

Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-κB pathway von Graham, K.M, Singh, R, Millman, G, Malnassy, G, Gatti, F, Bruemmer, K, Stefanski, C, Curtis, H, Sesti, J, Carlson, C.G

Volltext

Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia von Madan, V, Shyamsunder, P, Han, L, Mayakonda, A, Nagata, Y, Sundaresan, J, Kanojia, D, Yoshida, K, Ganesan, S, Hattori, N, Fulton, N, Tan, K T, Alpermann, T, Kuo, M C, Rostami, S, Matthews, J, Sanada, M, Liu, L-Z, Shiraishi, Y, Miyano, S, Chendamarai, E, Hou, H A, Malnassy, G, Ma, T, Garg, M, Ding, L W, Sun, Q Y, Chien, W, Ikezoe, T, Lill, M, Biondi, A, Larson, R A, Powell, B L, Lübbert, M, Chng, W J, Tien, H F, Heuser, M, Ganser, A, Koren-Michowitz, M, Kornblau, S M, Kantarjian, H M, Nowak, D, Hofmann, W K, Yang, H, Stock, W, Ghavamzadeh, A, Alimoghaddam, K, Haferlach, T, Ogawa, S, Shih, L Y, Mathews, V, Koeffler, H P

Volltext

Targeting multiple signal pathways simultaneously might provide effective therapeutic strategies in acute myeloid leukemia von Liu, H., Diaz-Flores, E., Poire, X., Koval, G., Malnassy, G., Le Beau, M. M., Shannon, K., Odenike, O., Stock, W.

Volltext

A phase I and pharmacodynamic (PD) study of the histone deacetylase (HDAC) inhibitor belinostat (BEL) plus azacitidine (AZC) in advanced myeloid malignancies von Odenike, O., Godley, L. A., Madzo, J., Karrison, T., Green, M., Artz, A. S., Mattison, R. J., Yee, K. W. L., Bennett, M., Fulton, N., Koval, G., Malnassy, G., Larson, R. A., Ratain, M. J., Stock, W.

Volltext

Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-[kappa]B pathway von Graham, K M, Singh, R, Millman, G, Malnassy, G, Gatti, F, Bruemmer, K, Stefanski, C, Curtis, H, Sesti, J, Carlson, C G

Volltext

Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway von Graham, K M, Singh, R, Millman, G, Malnassy, G, Gatti, F, Bruemmer, K, Stefanski, C, Curtis, H, Sesti, J, Carlson, C G

Volltext

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403 von Stock, Wendy, Luger, Selina M., Advani, Anjali S., Yin, Jun, Harvey, Richard C., Mullighan, Charles G., Willman, Cheryl L., Fulton, Noreen, Laumann, Kristina M., Malnassy, Greg, Paietta, Elisabeth, Parker, Edy, Geyer, Susan, Mrózek, Krzysztof, Bloomfield, Clara D., Sanford, Ben, Marcucci, Guido, Liedtke, Michaela, Claxton, David F., Foster, Matthew C., Bogart, Jeffrey A., Grecula, John C., Appelbaum, Frederick R., Erba, Harry, Litzow, Mark R., Tallman, Martin S., Stone, Richard M., Larson, Richard A.

Volltext

Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia von Alachkar, Houda, Mutonga, Martin B G, Metzeler, Klaus H, Fulton, Noreen, Malnassy, Gregory, Herold, Tobias, Spiekermann, Karsten, Bohlander, Stefan K, Hiddemann, Wolfgang, Matsuo, Yo, Stock, Wendy, Nakamura, Yusuke

Volltext

Favorable Outcomes for Older Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early Results of U.S. Intergroup Trial C10403 von Stock, Wendy, Luger, Selina M., Advani, Anjali S., Geyer, Susan, Harvey, Richard C., Mullighan, Charles G., Willman, Cheryl L., Malnassy, Greg, Parker, Edy, Laumann, Kristina M, Sanford, Ben, Marcucci, Guido, Paietta, Elisabeth M., Liedtke, Michaela, Claxton, David F., Foster, Matthew C., Appelbaum, Frederick R., Erba, Harry, Litzow, Mark R., Tallman, Martin S., Stone, Richard M., Larson, Richard A.

Volltext